In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...

Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...

Ratcheting up the tariff rhetoric has consistently sent the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average into ...

Billions of dollars worth of U.S. biomanufacturing plant development has been announced, and site selection will likely be ...

Odin Industries is proud to announce the acquisition of Florida based A Doc on Wheels, a respected provider of mobile medical services. Effective June 3, 2025, the company will be rebranded as Shield ...

About 15% of colon cancers are dMMR, which confers resistance to chemotherapy. ICIs have FDA approval for metastatic dMMR ...

Explore Faiz Siddiqui’s gripping portrayal of Elon Musk's rise through Tesla, Twitter, and tech disruption. From self-driving ...

Here are some highlights from the first half of the year: ...

Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...

Eli Lilly (NYSE:LLY) recently announced promising Phase 1 data for its folate receptor alpha antibody-drug conjugate, ...

Tech funds enjoyed a strong recovery while bonds suffered, according to FE fundinfo fund performance data for May. US trade ...